Maykin Ho

Maykin Ho has an estimated net worth of $2.8 Million. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS, INC., Neumora Therapeutics, Inc., BIOMARIN PHARMACEUTICAL INC, FIBROGEN INC, and PAREXEL INTERNATIONAL CORP.

2018 was Maykin Ho's most active year for acquiring shares with 8 total transactions. Maykin Ho's most active month to acquire stocks was the month of May. 2023 was Maykin Ho's most active year for disposing of shares, totalling 3 transactions. Maykin Ho's most active month to dispose stocks was the month of April. 2024 saw Maykin Ho paying a total of $0.00 for 140,673 shares, this is the most they've acquired in one year. In 2023 Maykin Ho cashed out on 13,495 shares for a total of $148,591.05, their largest year based on trade value.